therapeutic action: anxiety relief

Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report

mycolabadmin

A 41-year-old woman with Long-COVID experienced severe symptoms including fatigue, depression, anxiety, headaches, and brain fog that didn’t improve with traditional treatments. She decided to try psilocybin mushrooms and MDMA with guidance from a therapist. After multiple dosing sessions over several months, she reported roughly 80-90% improvement in her symptoms and was able to return to work and resume her studies. While this single case is promising, more research is needed to determine whether these psychedelics are truly safe and effective for Long-COVID.

Read More »

A review of the neuroscience of religion: an overview of the field, its limitations, and future interventions

mycolabadmin

This review examines how neuroscience studies the brain’s role in religious experiences and behaviors. While current brain imaging technology has revealed connections between specific brain regions and religious practices like prayer and meditation, these technologies limit what researchers can study because they require people to stay still. The authors suggest that newer technologies like functional near-infrared spectroscopy could allow scientists to study the full range of religious behaviors, including movement-based rituals that are important to many faiths.

Read More »

Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report

mycolabadmin

A 54-year-old man with terminal throat cancer received a single dose of LSD (100 μg) as part of psychedelic-assisted therapy delivered at his home. The treatment helped him experience relief from existential distress and feelings of peace. Six months later, he was in better psychological health, more motivated to pursue meaningful activities, and had discontinued pain medications while maintaining stability. This case demonstrates that psychedelic therapy can be safely administered at home for patients with life-threatening illnesses seeking existential relief.

Read More »

Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

mycolabadmin

This clinical trial is investigating whether psilocybin (a psychoactive compound found in certain mushrooms) combined with supportive counseling can help people with treatment-resistant obsessive-compulsive disorder. Researchers will give participants two doses of psilocybin while providing non-directive psychological support to help them process their experiences. The study aims to determine whether this approach is safe, tolerable, and effective at reducing OCD symptoms, and to understand the psychological mechanisms that might explain how it works.

Read More »
Scroll to Top